keyword
https://read.qxmd.com/read/36835497/integrative-roles-of-dopamine-pathway-and-calcium-channels-reveal-a-link-between-schizophrenia-and-opioid-use-disorder
#41
JOURNAL ARTICLE
Siroshini K Thiagarajan, Siew Ying Mok, Satoshi Ogawa, Ishwar S Parhar, Pek Yee Tang
Several theories have been proposed to explain the mechanisms of substance use in schizophrenia. Brain neurons pose a potential to provide novel insights into the association between opioid addiction, withdrawal, and schizophrenia. Thus, we exposed zebrafish larvae at 2 days post-fertilization (dpf) to domperidone (DPM) and morphine, followed by morphine withdrawal. Drug-induced locomotion and social preference were assessed, while the level of dopamine and the number of dopaminergic neurons were quantified...
February 17, 2023: International Journal of Molecular Sciences
https://read.qxmd.com/read/36809938/neurobehavioral-profiles-of-six-genetically-based-rat-models-of-schizophrenia-related-symptoms
#42
JOURNAL ARTICLE
Ignasi Oliveras, Toni Cañete, Daniel Sampedro-Viana, Cristóbal Río-Álamos, Adolf Tobeña, Maria G Corda, Osvaldo Giorgi, Alberto Fernández-Teruel
Schizophrenia is a chronic and severe mental disorder with high heterogeneity in its symptoms clusters. The effectiveness of drug treatments for the disorder is far from satisfactory. It is widely accepted that research with valid animal models is essential if we aim at understanding its genetic/neurobiological mechanisms and finding more effective treatments. The present article presents an overview of six genetically-based (selectively-bred) rat models/strains, which exhibit neurobehavioral schizophrenia- relevant features, i...
February 21, 2023: Current Neuropharmacology
https://read.qxmd.com/read/36756192/sleep-as-a-mediator-between-cannabis-use-and-psychosis-vulnerability-a-longitudinal-cohort-study
#43
JOURNAL ARTICLE
Julien Ouellet, Sean Spinney, Roxane Assaf, Elroy Boers, Audrey Livet, Stéphane Potvin, Patricia Conrod
OBJECTIVES: Increasing evidence implicates cannabis consumption as a key risk factor in the development of psychosis, but the mechanisms underpinning this relationship remain understudied. This study proposes to determine whether sleep disruption acts as a mediator of the cannabis-to-psychosis relationship. STUDY DESIGN: This longitudinal study assessed measures of cannabis use frequency, sleep quality (SQ), and psychotic-like experiences (PLEs) were collected using self-reported questionnaires...
January 2023: Schizophrenia bulletin open
https://read.qxmd.com/read/36677060/therapeutic-and-toxic-effects-of-valproic-acid-metabolites
#44
REVIEW
Natalia A Shnayder, Violetta V Grechkina, Aiperi K Khasanova, Elena N Bochanova, Evgenia A Dontceva, Marina M Petrova, Azat R Asadullin, German A Shipulin, Kuanysh S Altynbekov, Mustafa Al-Zamil, Regina F Nasyrova
Valproic acid (VPA) and its salts are psychotropic drugs that are widely used in neurological diseases (epilepsy, neuropathic pain, migraine, etc.) and psychiatric disorders (schizophrenia, bipolar affective disorder, addiction diseases, etc.). In addition, the indications for the appointment of valproate have been expanding in recent years in connection with the study of new mechanisms of action of therapeutic and toxic metabolites of VPA in the human body. Thus, VPA is considered a component of disease-modifying therapy for multiple tumors, neurodegenerative diseases (Huntington's disease, Parkinson's disease, Duchenne progressive dystrophy, etc...
January 16, 2023: Metabolites
https://read.qxmd.com/read/36589470/network-analysis-of-the-structure-of-the-core-symptoms-and-clinical-correlates-in-comorbid-schizophrenia-and-gambling-disorder
#45
JOURNAL ARTICLE
Roser Granero, Fernando Fernández-Aranda, Zsolt Demetrovics, Milagros Lara-Huallipe, Alex Morón-Fernández, Susana Jiménez-Murcia
UNLABELLED: Few studies have analyzed the clinical profile of treatment-seeking patients with the comorbid presence of schizophrenia (SCZ) and gambling disorder (GD), which warrants new research to assess the network structure of this complex mental condition. The aim of this study was to explore the organization of the symptoms and other clinical correlates of SCZ with GD. Network analysis was applied to a sample of N = 179 SCZ patients (age range: 19-70 years, mean=39.5, SD=9.9) who met clinical criteria for gambling disorder-related problems...
December 27, 2022: International Journal of Mental Health and Addiction
https://read.qxmd.com/read/36521279/psychosis-and-conduct-disorder-in-greek-forensic-patients-found-not-guilty-by-reason-of-insanity-differences-between-patients-with-and-those-without-a-history-of-conduct-disorder-in-childhood-or-adolescence
#46
JOURNAL ARTICLE
Maria Markopoulou, Fotios Chatzinikolaou, Maria-Valeria Karakasi, Athanasios Avramidis, Ioannis Nikolaidis, Pavlos Pavlidis, Athanasios Douzenis
Much epidemiological evidence converges in identifying distinct types of individuals suffering from schizophrenia who exhibit aggressive behavior: those with and those without a history of conduct disorder (CD) in childhood or adolescence. In this study a sample of Greek forensic patients suffering from psychotic disorders was examined regarding demographic, clinical, legal and psychometric characteristics. All patients had committed a crime and were found not guilty by reason of insanity (NGRIs) in a court of law...
December 13, 2022: International Journal of Law and Psychiatry
https://read.qxmd.com/read/36429911/special-care-patients-and-caries-prevalence-in-permanent-dentition-a-systematic-review
#47
REVIEW
Miguel Ramón Pecci-Lloret, María Pilar Pecci-Lloret, Francisco Javier Rodríguez-Lozano
Due to the increase in the population with special needs and the significant difficulty in their dental management, it is essential to analyze the caries prevalence in this group of patients. The systematic review was conducted following the PRISMA statement. A search was performed on 9 May 2022 and updated on 5 June 2022, in three databases: Pubmed, Scielo, and Cochrane library. Studies involving the analysis of caries in permanent teeth in patients with special needs were included. A total of 1277 studies were analyzed and 21 studies were selected...
November 17, 2022: International Journal of Environmental Research and Public Health
https://read.qxmd.com/read/36428541/antipsychotic-abuse-dependence-and-withdrawal-in-the-pediatric-population-a-real-world-disproportionality-analysis
#48
JOURNAL ARTICLE
Diane Merino, Alexandre O Gérard, Alexandre Destere, Florence Askenazy, Milou-Daniel Drici, Susanne Thümmler
Antipsychotic drugs (APs) aim to treat schizophrenia, bipolar mania, and behavioral symptoms. In child psychiatry, despite limited evidence regarding their efficacy and safety, APs are increasingly subject to off-label use. Studies investigating addictology-related symptoms in young people being scarce, we aimed to characterize the different patterns of AP misuse and withdrawal in children and adolescents relying on the WHO pharmacovigilance database (VigiBase® , Uppsala Monitoring Centre, Sweden). Using the standardized MedDRA Query 'drug abuse, dependence and withdrawal', disproportionality for each AP was assessed with the reporting odds ratio and the information component...
November 18, 2022: Biomedicines
https://read.qxmd.com/read/36414348/syndrome-of-subjective-doubles-as-a-rare-presentation-of-a-first-episode-psychosis
#49
JOURNAL ARTICLE
Joao Luis Martins Quarenta, Cláudia Mota Pinto, Catarina Pedro Fernandes, Pedro Morgado
In this paper, we report the case of a man in his 30s with a first-episode psychosis, characterised by a subtype of delusional misidentification syndrome in which the delusion of doubles is exclusively of the patient's own self. This subdivision can be termed 'syndrome of doubles of the self' or 'syndrome of subjective doubles'. Additionally, an examination of the patient's mental state showed paranoid delusions. After being evaluated in the emergency department, the patient was hospitalised, and medicated with antipsychotic drugs...
November 22, 2022: BMJ Case Reports
https://read.qxmd.com/read/36411566/differential-neurobiological-markers-in-phenotype-stratified-rats-modeling-high-or-low-vulnerability-to-compulsive-behavior-a-narrative-review
#50
JOURNAL ARTICLE
Elena Martín-González, Manuela Olmedo-Córdoba, Pilar Flores, Margarita Moreno-Montoya
Compulsivity is a key manifestation of inhibitory control deficit and a cardinal symptom in different neuropsychopathological disorders such as obsessive-compulsive disorder, schizophrenia, addiction, and attention-deficit hyperactivity disorder. Schedule-induced polydipsia (SIP), is an animal model to study compulsivity. In this procedure, rodents develop excessive and persistent drinking behavior under different food-reinforcement schedules, that are not related to homeostatic or regulatory requirements. However, there are important individual differences that support the role of high-drinker HD rats as a compulsive phenotype, characterized in different paradigms by inhibitory response deficit, cognitive inflexibility, and resistant to extinction behavior; with significant differences in response to pharmacological challenges, and relevant neurobiological alterations in comparison with the control group, the non-compulsive low drinker LD group on SIP...
November 21, 2022: Current Neuropharmacology
https://read.qxmd.com/read/36402243/metabotropic-glutamate-receptor-3-as-a-potential-therapeutic-target-for-psychiatric-and-neurological-disorders
#51
REVIEW
Shalini Dogra, Jason Putnam, P Jeffrey Conn
Glutamate is a major excitatory neurotransmitter in the central nervous system (CNS) and abnormalities in the glutamatergic system underlie various CNS disorders. As metabotropic glutamate receptor 3 (mGlu3 receptor) regulates glutamatergic transmission in various brain areas, emerging literature suggests that targeting mGlu3 receptors can be a novel approach to the treatment of psychiatric and neurological disorders. For example, mGlu3 receptor negative allosteric modulators (NAMs) induce rapid antidepressant-like effects in both acute and chronic stress models...
November 16, 2022: Pharmacology, Biochemistry, and Behavior
https://read.qxmd.com/read/36280752/could-psychedelic-drugs-have-a-role-in-the-treatment-of-schizophrenia-rationale-and-strategy-for-safe-implementation
#52
REVIEW
Gilly Wolf, Sandeep Singh, Karin Blakolmer, Leonard Lerer, Tzuri Lifschytz, Uriel Heresco-Levy, Amit Lotan, Bernard Lerer
Schizophrenia is a widespread psychiatric disorder that affects 0.5-1.0% of the world's population and induces significant, long-term disability that exacts high personal and societal cost. Negative symptoms, which respond poorly to available antipsychotic drugs, are the primary cause of this disability. Association of negative symptoms with cortical atrophy and cell loss is widely reported. Psychedelic drugs are undergoing a significant renaissance in psychiatric disorders with efficacy reported in several conditions including depression, in individuals facing terminal cancer, posttraumatic stress disorder, and addiction...
January 2023: Molecular Psychiatry
https://read.qxmd.com/read/36223840/an-rna-seq-study-of-the-mpfc-of-rats-with-different-addiction-phenotypes
#53
REVIEW
Ashley J McFalls, G Imperio Ceasar, Emma Woodward, Claire Krikorian, Stoltsfus Brooke, Benjamin Wronowski, Patricia S Grigson, Willard M Freeman, Kent E Vrana
Addiction is a disease of brain-reward circuitry whereby attention, motivation, memory and emotional systems become enslaved to the goal of seeking and acquiring drug, instead of responding to the natural rewards for which these systems evolved. At the intersection of reward/limbic structures, the medial prefrontal cortex (mPFC) receives and consolidates signals regarding environment and orchestrates the most appropriate response (i.e., decision-making and attention). As such, mPFC function plays a critical role in the vulnerability or resilience to drug addiction...
October 9, 2022: Brain Research Bulletin
https://read.qxmd.com/read/36170737/non-psychiatrist-healthcare-professionals-attitudes-toward-patients-with-mental-disorders-lower-scores-in-social-distance-as-a-fragile-facet-of-public-stigma-against-depression
#54
JOURNAL ARTICLE
Anna Yashikhina, Dmitry Romanov, Sergey Strelnik, Anna Gradinar, Ekaterina Markina, Natalia Kuvshinova, Daria Smirnova
BACKGROUND: The stigmatization by healthcare professionals (HP) of patients suffering from mental disorders is an important problem that interferes with the delivery of medical assistance. Social distancing by HP is an integral part of stigmatization, which differs between various mental disorders, as well as between psychiatrists (PSY) versus nonpsychiatrist healthcare professionals (NPHP). SUBJECTS AND METHODS: The study included 141 HP: PSY (n=20; 36.2±4.2 y...
September 2022: Psychiatria Danubina
https://read.qxmd.com/read/36099546/characterization-of-d3-autoreceptor-function-in-whole-zebrafish-brain-with-fast-scan-cyclic-voltammetry
#55
JOURNAL ARTICLE
Piyanka Hettiarachchi, Michael A Johnson
Zebrafish ( Danio rerio ) are ideal model organisms for investigating nervous system function, both in health and disease. Nevertheless, functional characteristics of dopamine (DA) release and uptake regulation are still not well-understood in zebrafish. In this study, we assessed D3 autoreceptor function in the telencephalon of whole zebrafish brains ex vivo by measuring the electrically stimulated DA release ([DA]max ) and uptake at carbon fiber microelectrodes with fast-scan cyclic voltammetry. Treatment with pramipexole and 7-OH-DPAT, selective D3 autoreceptor agonists, sharply decreased [DA]max ...
September 13, 2022: ACS Chemical Neuroscience
https://read.qxmd.com/read/36059987/dopamine-receptors-is-it-possible-to-become-a-therapeutic-target-for-depression
#56
REVIEW
Fangyi Zhao, Ziqian Cheng, Jingjing Piao, Ranji Cui, Bingjin Li
Dopamine and its receptors are currently recognized targets for the treatment of several neuropsychiatric disorders, including Parkinson's disease, schizophrenia, some drug use addictions, as well as depression. Dopamine receptors are widely distributed in various regions of the brain, but their role and exact contribution to neuropsychiatric diseases has not yet been thoroughly studied. Based on the types of dopamine receptors and their distribution in different brain regions, this paper reviews the current research status of the molecular, cellular and circuit mechanisms of dopamine and its receptors involved in depression...
2022: Frontiers in Pharmacology
https://read.qxmd.com/read/36056214/selective-taar1-agonists-induce-conditioned-taste-aversion
#57
JOURNAL ARTICLE
Jianfeng Liu, Ruyan Wu, Bernard Johnson, Yanan Zhang, Qing Zhu, Jun-Xu Li
RATIONALE: Trace amine-associated receptor 1 (TAAR1) is the best-studied receptor of trace amines, a group of biogenic amines expressed at a relatively low level in the mammalian brain. Growing evidence suggests that TAAR1 plays a critical role in various neuropsychiatric disorders. Given that selective TAAR1 agonists were shown to produce pro-cognition and antipsychotic-like effects as well as to suppress drug use and relapse, they have been proposed to be novel treatments for mental disorders such as schizophrenia and addiction...
October 2022: Psychopharmacology
https://read.qxmd.com/read/36038019/targeting-mglur2-3-for-treatment-of-neurodegenerative-and-neuropsychiatric-diseases
#58
REVIEW
Si Han Li, Khaled S Abd-Elrahman, Stephen S G Ferguson
Glutamate is the primary excitatory neurotransmitter in the brain and plays critical roles in all aspects of neuronal function. Disruption of normal glutamate transmission has been implicated in a variety of neurodegenerative and neuropsychiatric diseases. Glutamate exerts its effect through ionotropic and metabotropic glutamate receptors (mGluRs). mGluR2 and mGluR3 are members of the Group II mGluR family and their activation leads to the inhibition of glutamate release from presynaptic nerve terminals and is also poised upstream of a myriad of signaling pathways in postsynaptic nerve terminals and neuroglia...
August 26, 2022: Pharmacology & Therapeutics
https://read.qxmd.com/read/36009006/design-synthesis-and-pharmacological-evaluation-of-novel-conformationally-restricted-n-arylpiperazine-derivatives-characterized-as-d-2-d-3-receptor-ligands-candidates-for-the-treatment-of-neurodegenerative-diseases
#59
JOURNAL ARTICLE
Thayssa Tavares da Silva Cunha, Rafaela Ribeiro Silva, Daniel Alencar Rodrigues, Pedro de Sena Murteira Pinheiro, Thales Kronenberger, Carlos Maurício R Sant'Anna, François Noël, Carlos Alberto Manssour Fraga
Most neurodegenerative diseases are multifactorial, and the discovery of several molecular mechanisms related to their pathogenesis is constantly advancing. Dopamine and dopaminergic receptor subtypes are involved in the pathophysiology of several neurological disorders, such as schizophrenia, depression and drug addiction. For this reason, the dopaminergic system and dopamine receptor ligands play a key role in the treatment of such disorders. In this context, a novel series of conformationally restricted N -arylpiperazine derivatives ( 5a - f ) with a good affinity for D2 /D3 dopamine receptors is reported herein...
August 12, 2022: Biomolecules
https://read.qxmd.com/read/35978843/case-report-functional-and-symptomatic-improvement-with-cariprazine-in-various-psychiatric-patients-a-case-series
#60
Tommaso Vannucchi, Costanza Taddeucci, Lorenzo Tatini
Cariprazine is a third-generation antipsychotic medication approved for the treatment of schizophrenia and bipolar disorder, with unique pharmacodynamic and pharmacokinetic properties. In this case series, the functional and symptomatic improvement of three patients who had been diagnosed with different psychiatric disorders and who exhibited various symptoms from psychotic to mood symptoms is described. The first case is about a young male patient with bipolar disorder and cocaine abuse who managed to become abstinent from cariprazine...
2022: Frontiers in Psychiatry
keyword
keyword
91771
3
4
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.